HYDRALAZINE HYDROCHLORIDE
NDC 72241-004, hydralazine hydrochloride, tablet, from Modavar Pharmaceuticals LLC.
- Product NDC
- 72241-004
- Status
- Listed
- Labeler
- Modavar Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203845
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72241-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72241-004-05 | 72241000405 | 100 TABLET in 1 BOTTLE (72241-004-05) |
| 72241-004-11 | 72241000411 | 1000 TABLET in 1 BOTTLE (72241-004-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a456bc34-0c79-44f4-9119-50028a978f5fNADAC price for package 72241000411
GET /v1/drugs/nadac/72241000411
Use it
Look up 72241-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72241-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72241-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.